2.51
Tharimmune Inc (THAR) 最新ニュース
Crypto Company Creates Bizarre Drug - Futurism
Tharimmune Stock Plummets -46% With 9-Day Losing Streak - Trefis
Using Bollinger Bands to evaluate Tharimmune Inc.Gap Up & Expert Curated Trade Setups - newser.com
Will Tharimmune Inc. stock benefit from sector rotationPortfolio Performance Report & Free Accurate Trade Setup Notifications - newser.com
Why analysts upgrade Tharimmune Inc. stockJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
How resilient is Tharimmune Inc. stock in market downturnsWatch List & Trade Opportunity Analysis Reports - newser.com
Is Tharimmune Inc. stock a buy for dividend growthTrade Exit Summary & Stepwise Swing Trade Plans - newser.com
What insider trading reveals about Tharimmune Inc. stock2025 Momentum Check & Safe Capital Growth Tips - newser.com
Is Tharimmune Inc. stock attractive for retirement portfoliosWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Will Tharimmune Inc. stock deliver long term returnsInsider Selling & Verified Momentum Stock Alerts - newser.com
What the charts say about Tharimmune Inc. todayMarket Risk Report & Pattern Based Trade Signal System - newser.com
Will earnings trigger a reversal in Tharimmune Inc.July 2025 Sentiment & Expert Verified Movement Alerts - newser.com
Using data models to predict Tharimmune Inc. stock movementWeekly Investment Summary & Accurate Buy Signal Alerts - newser.com
Will Tharimmune Inc. stock sustain high P E ratiosWall Street Watch & High Accuracy Swing Entry Alerts - newser.com
Is Tharimmune Inc. still worth holding after the dip2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
Tharimmune Shares Jump After FDA Signals Support for TH104 Modeling Plan - MSN
Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset - MarketScreener
Tharimmune rises after US FDA backs opioid overdose prevention drug plan - TradingView
Tharimmune stock rises after FDA provides positive feedback on TH104 By Investing.com - Investing.com Nigeria
Tharimmune stock rises after FDA provides positive feedback on TH104 - Investing.com
Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids - Stock Titan
Tharimmune appoints Sireesh Appajosyula as interim CFO through year-end - Investing.com
Tharimmune appoints Sireesh Appajosyula as interim CFO through year-end By Investing.com - Investing.com UK
Tharimmune appoints Sireesh Appajosyula as interim CFO on Nov 7SEC filing - MarketScreener
Tharimmune Closes $545M Private Placement for Blockchain Strategy - The Globe and Mail
Tharimmune makes a pivot into digital assets, raises approximately $540 million via a private placement - MSN
Tharimmune entered ATM sales agreement worth up to $64.9 millionSEC filing - MarketScreener
Tharimmune closes $545 million private placement for Canton Coin strategy By Investing.com - Investing.com Australia
Tharimmune: $545 Million Private Placement Closed To Advance Canton Coin Treasury Strategy - Pulse 2.0
大文字化:
|
ボリューム (24 時間):